Search Editorial Photos
"PHARMACEUTICAL LABORATORY"
246 professional editorial images found
#12679536
27 August 2025
The HBL Pharma logo is seen on the facade of the laboratory as the investigation continues into possible quality deviations in the production of batches of medicinal fentanyl linked to dozens of hospital deaths in Buenos Aires, Argentina, on August 26, 2025.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#12679538
27 August 2025
The HBL Pharma logo is seen on the facade of the laboratory as the investigation continues into possible quality deviations in the production of batches of medicinal fentanyl linked to dozens of hospital deaths in Buenos Aires, Argentina, on August 26, 2025.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#12679539
27 August 2025
The HBL Pharma logo is seen on the facade of the laboratory as the investigation continues into possible quality deviations in the production of batches of medicinal fentanyl linked to dozens of hospital deaths in Buenos Aires, Argentina, on August 26, 2025.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#12624344
8 August 2025
Edmundo Jimenez Luna, the director of Carnot Laboratories, speaks during a briefing about the 12 billion pesos investment in pharmaceutical companies as part of Plan Mexico, at the National Palace in Mexico City, Mexico, on August 7, 2025.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#12624350
8 August 2025
Edmundo Jimenez Luna, the director of Carnot Laboratories, speaks during a briefing about the 12 billion pesos investment in pharmaceutical companies as part of Plan Mexico, at the National Palace in Mexico City, Mexico, on August 7, 2025.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#12624355
8 August 2025
Mexican President Claudia Sheinbaum Pardo, accompanied by Mexico's Economic Minister Marcelo Ebrard Casaubon, Mexico's Health Minister David Kershenobich Stalnikowitz, Carnot Laboratories' director Edmundo Jimenez Luna, Bayer's director in Mexico Manuel Bravo Pereyra, AstraZeneca Mexico CEO Julio Ordaz, Michoacan Governor Alfredo Ramirez Bedolla, Artifibras CEO David Martinez Gomez Tagle, and Pharma Bayer de Mexico CEO Daniel Londero, pose for photos after the Plan Mexico briefing at the National Palace in Mexico City, Mexico, on August 7, 2025.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#12624803
8 August 2025
The signage of the Bayer AG pharmaceutical and biotechnology company is seen at one of its industrial sites in Wuppertal, North Rhine-Westphalia, Germany, on July 31, 2025.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#12624805
8 August 2025
The signage of the Bayer AG pharmaceutical and biotechnology company is seen at one of its industrial sites in Wuppertal, North Rhine-Westphalia, Germany, on July 31, 2025.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#12624802
8 August 2025
Signage and the building of the Bayer AG pharmaceutical and biotechnology company are seen at one of its industrial sites in Wuppertal, North Rhine-Westphalia, Germany, on July 31, 2025.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#12624804
8 August 2025
Signage and the building of the Bayer AG pharmaceutical and biotechnology company are seen at one of its industrial sites in Wuppertal, North Rhine-Westphalia, Germany, on July 31, 2025.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#12624806
8 August 2025
Signage and the building of the Bayer AG pharmaceutical and biotechnology company are seen at one of its industrial sites in Wuppertal, North Rhine-Westphalia, Germany, on July 31, 2025.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#12624807
8 August 2025
Signage and the building of the Bayer AG pharmaceutical and biotechnology company are seen at one of its industrial sites in Wuppertal, North Rhine-Westphalia, Germany, on July 31, 2025.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#12624808
8 August 2025
Signage and the building of the Bayer AG pharmaceutical and biotechnology company are seen at one of its industrial sites in Wuppertal, North Rhine-Westphalia, Germany, on July 31, 2025.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#12624809
8 August 2025
Signage and the building of the Bayer AG pharmaceutical and biotechnology company are seen at one of its industrial sites in Wuppertal, North Rhine-Westphalia, Germany, on July 31, 2025.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#12526023
3 July 2025
The CEO of Kener Laboratories, Federico Prince Laris, speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma for the manufacturing of specialized medications in Mexico at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#12526016
3 July 2025
Mexico's President Claudia Sheinbaum Pardo speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.